Century Therapeutics (IPSC) Current Assets (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Current Assets of $139.0 million for Q1 2026, down 18.03% year-over-year from $169.6 million in Q1 2025, and up 15.13% quarter-over-quarter from $120.8 million in Q4 2025.
Century Therapeutics (IPSC) Current Assets (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Current Assets for 7 consecutive years, with $139.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 18.03% year-over-year to $139.0 million; the TTM figure through Mar 2026 stood at $139.0 million (down 18.03% YoY), while the FY2025 annual figure was $120.8 million, down 37.76% from the prior year.
- Current Assets rose to $139.0 million in Q1 2026 per IPSC's latest filing, from $120.8 million in the prior quarter.
- Across five years, Current Assets topped out at $383.8 million in Q2 2022 and bottomed at $120.8 million in Q4 2025.
- Historically, Current Assets has averaged $219.4 million across 5 years, with a median of $194.1 million in 2024.
- Annual changes were most pronounced in 2022 — Current Assets soared 40.13% — and 2023, when it plunged 57.98%.
- Century Therapeutics' Current Assets stood at $319.7 million in 2022, then slumped by 44.64% to $177.0 million in 2023, then advanced by 9.64% to $194.1 million in 2024, then sank by 37.76% to $120.8 million in 2025, then increased by 15.13% to $139.0 million in 2026.
- Business Quant data shows IPSC's Current Assets at $139.0 million in Q1 2026, $120.8 million in Q4 2025, and $137.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 124.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 124.77 Mn |
| Mar 31, 2026 | 139.04 Mn |
| Dec 31, 2025 | 120.77 Mn |
| Sep 30, 2025 | 137.71 Mn |
| Jun 30, 2025 | 160.17 Mn |
| Mar 31, 2025 | 169.63 Mn |
| Dec 31, 2024 | 194.05 Mn |
| Sep 30, 2024 | 206.01 Mn |
| Jun 30, 2024 | 203.48 Mn |
| Mar 31, 2024 | 199.81 Mn |
| Dec 31, 2023 | 176.99 Mn |
| Sep 30, 2023 | 173.70 Mn |
| Jun 30, 2023 | 161.28 Mn |
| Mar 31, 2023 | 255.93 Mn |
| Dec 31, 2022 | 319.72 Mn |
| Sep 30, 2022 | 361.64 Mn |
| Jun 30, 2022 | 383.79 Mn |
| Mar 31, 2022 | 365.26 Mn |
| Dec 31, 2021 | 228.15 Mn |
| Sep 30, 2021 | 300.40 Mn |